- Home
- CRL
CRL
Charles River Laboratories International Inc.
as 03-12-2025 12:34pm EST
| Founded: | 1947 | Country: | United States |
| Employees: | N/A | City: | WILMINGTON |
| Market Cap: | N/A | IPO Year: | 2000 |
| Target Price: | $194.62 | AVG Volume (30 days): | 1.5M |
| Analyst Decision: | Hold | Number of Analysts: | 15 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.20 | EPS Growth: | -97.83 |
| 52 Week Low/High: | $150.79 - $274.77 | Next Earning Date: | 05-08-2025 |
| Revenue: | $4,049,989,000 | Revenue Growth: | -1.92% |
| Revenue Growth (this year): | -4.44% | Revenue Growth (next year): | 4.65% |
Stock Insider Trading Activity of Charles River Laboratories International Inc. (CRL)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| FOSTER JAMES C | CRL | Chairman, President and CEO | Feb 20 '25 | Buy | $165.01 | 6,075 | $1,002,435.75 | 183,639 | |
| Girshick Birgit | CRL | Corporate Executive VP & COO | Feb 20 '25 | Buy | $164.63 | 1,514 | $249,249.82 | 55,058 | |
| LaPlume Joseph W | CRL | EVP, Corp Strategy & Develop | Feb 20 '25 | Sell | $162.50 | 4,400 | $715,000.00 | 20,013 |
Latest Charles River Laboratories International Inc. News
CRL Breaking Stock News: Dive into CRL Ticker-Specific Updates for Smart Investing
Business Wire
a day ago
Charles River Laboratories to Present at Barclays Global Healthcare Conference
StockStory
7 days ago
Spotting Winners: Charles River Laboratories (NYSE:CRL) And Drug Development Inputs & Services Stocks In Q4
MT Newswires
8 days ago
Charles River Laboratories Shares Rise After Citigroup Upgrade
MT Newswires
8 days ago
Citigroup Upgrades Charles River Laboratories International to Neutral From Sell, Adjusts Price Target to $175 From $155
MT Newswires
9 days ago
Redburn Atlantic Upgrades Charles River Laboratories International to Neutral From Sell, Adjusts PT to $188 From $171
Insider Monkey
12 days ago
Bell Global Equities Sold Charles River Laboratories International (CRL) Due To Its Potential For On-going Risk To Earnings
Simply Wall St.
14 days ago
Charles River Laboratories International's (NYSE:CRL) Soft Earnings Don't Show The Whole Picture
Hospital Management
15 days ago
SGH and Charles River team up for CGMP cell banking services
Compare CRL vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CRL Charles River Laboratories International Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.